or Try an Advanced Search...

    Technical Analysis for DSGN - Design Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 3.25 -2.99% -0.10
    DSGN closed down 2.99 percent on Monday, July 1, 2024, on 72 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical DSGN trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -2.99%
    Oversold Stochastic Weakness -2.99%
    Stochastic Buy Signal Bullish -2.99%
    Wide Bands Range Expansion -2.99%
    Oversold Stochastic Weakness -2.99%
    Wide Bands Range Expansion 0.62%
    Down 3 Days in a Row Weakness 0.62%
    Lower Bollinger Band Touch Weakness 0.62%
    Older End-of-Day Signals for DSGN ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 8 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    60 Minute Opening Range Breakdown about 8 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DSGN Chart by TradingView
    Basic chart:

    Profile

    Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders

    Is DSGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 23 The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains
    May 10 Design Therapeutics Inc (DSGN) Q1 2024 Earnings: A Detailed Financial and Strategic Review
    May 9 Design Therapeutics GAAP EPS of -$0.20
    May 8 Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones
    May 7 Design Therapeutics climbs as Piper Sandler upgrades on pipeline
    May 7 Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
    Mar 27 Independent Director of Design Therapeutics Picks Up 88% More Stock
    Mar 26 Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
    Mar 20 Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
    Mar 20 Q4 2023 Design Therapeutics Inc Earnings Call
    See more DSGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.31
    52 Week Low 1.94
    Average Volume 231,310
    200-Day Moving Average 2.93
    50-Day Moving Average 3.92
    20-Day Moving Average 3.66
    10-Day Moving Average 3.39
    Average True Range 0.21
    RSI (14) 35.90
    ADX 16.67
    +DI 18.05
    -DI 23.89
    Chandelier Exit (Long, 3 ATRs) 3.57
    Chandelier Exit (Short, 3 ATRs) 3.81
    Upper Bollinger Bands 4.29
    Lower Bollinger Band 3.03
    Percent B (%b) 0.17
    BandWidth 34.48
    MACD Line -0.20
    MACD Signal Line -0.17
    MACD Histogram -0.0385
    Fundamentals Value
    Market Cap 182.01 Million
    Num Shares 56 Million
    EPS -1.29
    Price-to-Earnings (P/E) Ratio -2.52
    Price-to-Sales 22642.01
    Price-to-Book 0.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.46
    Resistance 3 (R3) 3.47 3.41 3.43
    Resistance 2 (R2) 3.41 3.36 3.41 3.41
    Resistance 1 (R1) 3.33 3.32 3.30 3.32 3.40
    Pivot Point 3.27 3.27 3.26 3.27 3.27
    Support 1 (S1) 3.19 3.22 3.16 3.18 3.10
    Support 2 (S2) 3.13 3.18 3.13 3.09
    Support 3 (S3) 3.05 3.13 3.08
    Support 4 (S4) 3.04